Immune Response of Healthy Adults to the Ingested Probiotic Lactobacillus casei Shirota

Scandinavian Journal of Immunology

Volumn 84, Issue 6, 2016, Pages 353-364

  Harbige, L S ^a   Pinto, E ^a   Allgrove, J ^b   Thomas, L V ^c  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c Yakult UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA7 INTEGRIN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 4; IONOMYCIN; PROBIOTIC AGENT; TETANUS ANTIBODY; TUMOR NECROSIS FACTOR; BETA INTEGRIN; LEUKOCYTE ANTIGEN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIGEN EXPRESSION; ARTICLE; BEVERAGE; BLOOD CELL; CD3+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INFLUENZA A; INTRACELLULAR SPACE; LACTOBACILLUS CASEI; MALE; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; SALIVATION; T LYMPHOCYTE ACTIVATION; TETANUS; ADOLESCENT; B LYMPHOCYTE; CELL CULTURE; CLINICAL TRIAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SALIVA; T LYMPHOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMMUNOGLOBULIN A; INTEGRIN BETA CHAINS; INTERFERON-GAMMA; INTERLEUKIN-4; KILLER CELLS, NATURAL; LACTOBACILLUS CASEI; LYMPHOCYTE ACTIVATION; MALE; PROBIOTICS; SALIVA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 85006996392     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12495     Document Type: Article

References (94)

1. Freitas M, Tavan E, Cayuela C, Diop L, Sapin C, Trugnan G. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 2003;95:503–6.
2. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2001;2:27–42.
3. Cong Y, Weaver CT, Lazenby A, Elson CO. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002;169:6112–9.
4. van Wijk F, Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009;21:130–8.
5. Kwon HK, Lee CG, So JS et al. Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 2010;107:2159–64.
6. Rescigno M, Lopatin U, Chieppa M. Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr Opin Immunol 2008;20:669–75.
7. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004;5:104–12.
8. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 2008;84:468–76.
9. Chiba Y, Shida K, Nagata S et al. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 2010;130:352–62.
10. Weiss G, Rasmussen S, Zeuthen LH et al. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 2010;131:268–81.
11. Castillo NA, Perdigon G, de Moreno de Leblanc A. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol 2011;11:177.
12. Jeon SG, Kayama H, Ueda Y et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012;8:e1002714.
13. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology 2009;128 (1 Suppl.):e523–31.
14. Yasuda E, Serata M, Sako T. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol 2008;74:4746–55.
15. Shida K, Kiyoshima-Shibata J, Kaji R, Nagaoka M, Nanno M. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms. Immunology 2009;128 (1 Suppl.):e858–69.
16. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M, Shida K. Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 2010;184:3505–13.
17. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541–51.
18. Borruel N, Casellas F, Antolin M et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003;98:865–70.
19. Hacini-Rachinel F, Nancey S, Boschetti G et al. CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells. J Immunol 2009;183:5477–86.
20. Hegazy SK, El-Bedewy MM. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 2010;16:4145–51.
21. Spiller R. Review article: Probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008;28:385–96.
22. Ford AC, Quigley EM, Lacy BE et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547–61; quiz 1546, 1562.
23. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008;32:147–52.
24. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004;70:1176–81.
25. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39–44.
26. Bosch M, Mendez M, Perez M, Farran A, Fuentes MC, Cune J. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr Hosp 2012;27:504–9.
27. Suzuki K, Fagarasan S. How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol 2008;29:523–31.
28. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006;13:219–26.
29. Park JH, Um JI, Lee BJ et al. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol 2002;219:22–7.
30. Zanini K, Marzotto M, Castellazzi A, Borsari A, Dellaglio F, Toriani S. The effects of fermented milks with simple and complex probiotic mixtures on the intestinal microbiota and immune response of healthy adults and children. Int Dairy J 2007;17:1332–43.
31. Parra D, De Morentin BM, Cobo JM, Mateos A, Martinez JA. Monocyte function in healthy middle-aged people receiving fermented milk containing Lactobacillus casei. J Nutr Health Aging 2004;8:208–11.
32. Meyer AL, Elmadfa I, Herbacek I, Micksche M. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. J Hum Nutr Diet 2007;20:590–8.
33. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011;21:55–64.
34. Clancy RL, Gleeson M, Cox A et al. Reversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilus. Br J Sports Med 2006;40:351–4.
35. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109:119–21.
36. de Moreno de LeBlanc A, Dogi CA, Galdeano CM, Carmuega E, Weill R, Perdigon G. Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunol 2008;9:27.
37. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007;25:5467–84.
38. Johansen FE, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 2005;106:593–600.
39. Gleeson M, Hall ST, McDonald WA, Flanagan AJ, Clancy RL. Salivary IgA subclasses and infection risk in elite swimmers. Immunol Cell Biol 1999;77:351–5.
40. Furtado PB, Whitty PW, Robertson A et al. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1. J Mol Biol 2004;338:921–41.
41. Garcia-Nieto RM, Rico-Mata R, Arias-Negrete S, Avila EE. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity. Parasitol Int 2008;57:417–23.
42. O'Connel E, Allgrove J, Pollard L, Xiang M, Harbige LS. A pilot study investigating the effects of Yakult fermented milk drink (L. casei Shirota) on salivary IFN-g, sIgA, IgA1 and IgA2 in healthy volunteers. Proc Nutr Soc 2010;69 (OCE3):E267.
43. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003;7:75–7.
44. de Vrese M, Winkler P, Rautenberg P et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 2006;24:6670–4.
45. Tubelius P, Stan V, Zachrisson A. Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ Health 2005;4:25.
46. Shida K, Sato T, Iizuka R et al. Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers. Eur J Nutr 2015, Sep 29. DOI: 10.1007/s00394-015-1056-1 [Epub ahead of print].
47. Jespersen L, Tarnow I, Eskesen D et al. Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Clin Nutr 2015;101:1188–96.
48. King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr 2014;112:41–54.
49. Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P, Lawrence C. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sport Nutr Exerc Metab 2012;22:235–42.
50. Borrego F, Robertson MJ, Ritz J, Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptors. Immunology 1999;97:159–65.
51. Dong H, Rowland I, Tuohy KM, Thomas LV, Yaqoob P. Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol 2010;161:378–88.
52. Takeda K, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 2007;137 (3 Suppl. 2):791S–3S.
53. Dong H, Rowland I, Thomas LV, Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr 2013;52:1853–63.
54. Reale M, Boscolo P, Bellante V et al. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. Br J Nutr 2012;108:308–14.
55. Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000;78:67–73.
56. Ogawa T, Asai Y, Tamai R et al. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol 2006;143:103–9.
57. Starovoitova SO, Tymoshok NO, Horchakov V, Spivak M. Immunomodulation characteristics of Lactobacillus genus bacteria. Mikrobiol Z 2009;71:41–7.
58. Nagai T, Makino S, Ikegami S, Itoh H, Yamada H. Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. Int Immunopharmacol 2011;11:2246–50.
59. Lee YN, Youn HN, Kwon JH et al. Sublingual administration of Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against influenza virus infection in mice. Antiviral Res 2013;98:284–90.
60. Seifert S, Bub A, Franz CM, Watzl B. Probiotic Lactobacillus casei Shirota supplementation does not modulate immunity in healthy men with reduced natural killer cell activity. J Nutr 2011;141:978–84.
61. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000;356:1795–9.
62. Shida K, Nomoto K. Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res 2013;138:808–14.
63. Farstad IN, Norstein J, Brandtzaeg P. Phenotypes of B and T cells in human intestinal and mesenteric lymph. Gastroenterology 1997;112:163–73.
64. Ohman L, Isaksson S, Lundgren A, Simren M, Sjovall H. A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:980–6.
65. Gorfu G, Rivera-Nieves J, Ley K. Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 2009;9:836–50.
66. Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002;110:617–23.
67. Ozdemir O. Any benefits of probiotics in allergic disorders? Allergy Asthma Proc 2010;31:103–11.
68. Smelt MJ, de Haan BJ, Bron PA et al. L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS ONE 2012;7:e47244.
69. Yesilova Y, Calka O, Akdeniz N, Berktas M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 2012;24:189–93.
70. Ivory K, Chambers SJ, Pin C, Prieto E, Arques JL, Nicoletti C. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 2008;38:1282–9.
71. Ya T, Zhang Q, Chu F et al. Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China. BMC Immunol 2008;9:68.
72. Vissers YM, Snel J, Zuurendonk PF, Kleerebezem M, Wichers HJ, Savelkoul HF. Lactobacillus strains differentially modulate cytokine production by hPBMC from pollen-allergic patients. FEMS Immunol Med Microbiol 2011;61:28–40.
73. Mechoud MA, Mateos MV, de Valdez GF, Villena J, Salvador GA, Rodriguez AV. Lactobacillus reuteri CRL1098 soluble factors modulate tumor necrosis factor alpha production in peripheral blood mononuclear cells: involvement of lipid rafts. Int Immunopharmacol 2012;14:446–53.
74. Villena J, Chiba E, Tomosada Y et al. Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C). BMC Immunol 2012;13:53.
75. Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 2006;146:109–15.
76. Ongol MP, Iguchi T, Tanaka M et al. Potential of selected strains of lactic acid bacteria to induce a Th1 immune profile. Biosci Biotechnol Biochem 2008;72:2847–57.
77. Ghadimi D, Folster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeir J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008;213:677–92.
78. Shida K, Nanno M, Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2011;2:109–14.
79. Iwabuchi N, Yonezawa S, Odamaki T, Yaeshima T, Iwatsuki K, Xiao JZ. Immunomodulating and anti-infective effects of a novel strain of Lactobacillus paracasei that strongly induces interleukin-12. FEMS Immunol Med Microbiol 2012;66:230–9.
80. Shida K, Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immunol 2008;29:565–73.
81. Zhao J, Zhao J, Perlman S. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R. PLoS ONE 2012;7:e46241.
82. Donkor ON, Ravikumar M, Proudfoot O et al. Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin Exp Immunol 2012;167:282–95.
83. Hunter CA, Bermudez L, Beernink H, Waegell W, Remington JS. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to toxoplasma gondii. Eur J Immunol 1995;25:994–1000.
84. Strober W, Kelsall B, Fuss I et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61–4.
85. O'Garra A, Murphy KM. From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development. Nat Immunol 2009;10:929–32.
86. Habil N, Beal J, Foey AD. Lactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production. Int J Probiotics Prebiotics 2012;7:1–12.
87. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009;27:5677–84.
88. Martinez-Gomez F, Santiago-Rosales R, Ramon Bautista-Garfias C. Effect of Lactobacillus casei Shirota strain intraperitoneal administration in CD1 mice on the establishment of Trichinella spiralis adult worms and on IgA anti-T. spiralis production. Vet Parasitol 2009;162:171–5.
89. Mendonca FH, Santos SS, Faria Ida S, Goncalves e Silva CR, Jorge AO, Leao MV. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J 2012;23:534–8.
90. Weiner HL. Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 1997;48:341–51.
91. Van Puyenbroeck K, Hens N, Coenen S et al. Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr 2012;95:1165–71.
92. Olivares M, Diaz-Ropero MP, Sierra S et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 2007;23:254–60.
93. You J, Dong H, Mann ER, Knight SC, Yaqoob P. Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology 2014;219:138–48.
94. You J, Yaqoob P. Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486. FEMS Immunol Med Microbiol 2012;66:353–62.